Navigation Links
Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip
Date:6/12/2011

TRODUCTION 137

DRIVING FORCES FOR ADOPTION OF BIOCHIP DIAGNOSTIC PLATFORMS 137

BIOMARKER DISCOVERY AND VALIDATION 137

CLINICAL ACCEPTANCE OF BIOMARKER-BASED TESTS 138

TABLE 60 RATE OF ADOPTION OF DNA MICROARRAY DIAGNOSTICS TESTS 139

MICROARRAY STANDARDIZATION EFFORTS 140

Microarray Quality Control Project 140

External RNA Controls Consortium (ERCC) Study 141

Association of Bimolecular Resource Facilities (ABRF) CGH Microarray Platform Study 142

TABLE 61 COMPARISON OF ARRAY-CGH PLATFORMS 142

OVERVIEW OF MDX 143

INTRODUCTION 143

BENEFITS OF BIOCHIPS AS AN MDX PLATFORM 144

Benefits of Biochips as an MDX Platform (Continued) 145

FIGURE 23 BIOCHIPS TARGET HIGH GROWTH, HIGH MARGIN PORTION OF THE IVD MARKET 146

TABLE 62 BIOTECHNOLOGY DRUGS APPROVED BY THE FDA, 1980–2008 (NUMBER) 147

PHARMACOGENOMICS TESTS 147

Pharmacogenomics Tests (Continued) 148

STRATEGIES FOR COMMERCIALIZING PGX TESTS 149

MDX MARKET PENETRATION CHALLENGES 150

TABLE 63 COMPARISON OF DNA-BASED MDX PLATFORMS 151

TABLE 64 FACTORS AFFECTING PENETRATION OF BIOCHIPS INTO THE MDX MARKET 152

MDX Market Penetration Challenges (Continued) 153

MDX MARKET SEGMENTS 154

MDX TEST SENSITIVITY AND SPECIFICITY 155

FIGURE 24 SENSITIVITY AND SPECIFICITY 156

STATUS OF BIOCHIPS DIAGNOSTICS BY INDICATION 157

SUMMARY OF BIOCHIPS DIAGNOSTICS 157

CANCER OVERVIEW 157

TABLE 65 U.S. INCIDENCE AND TREATMENT DECISIONS FOR SELECTED CANCERS, 2009 157

HEMATOLOGICAL CANCERS 158

BLADDER CANCER 158

BREAST CANCER 159

Breast Cancer Screening 159

Prognosis and Pharmacogenetics Tests 160

FIGURE 25 BREAST CANCER TREATMENT DECISION TREE FOR ONCOTYPE DX 161

TABLE 66 ESTIMATED NUMBER OF ANNUAL BREAST CANCER TREATMENT DECISIONS IN THE U.
'/>"/>

SOURCE S OF COMPETITIVE ADVANTAGE IN DNA MICROARRAYS 265
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology news :

1. Reportlinker Adds Biometrics: Technologies and Global Markets
2. Reportlinker Adds Enzymes in Drug Manufacturing
3. Reportlinker Adds Bioinformatics - A Global Market Overview
4. Reportlinker Adds Global Biometric Forecast to 2012
5. Reportlinker Adds Global Bioinformatics Industry
6. Reportlinker Adds Indian Biometric Market
7. Reportlinker Adds Biometrics: Technologies and Global Markets
8. Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip
9. Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
10. Reportlinker Adds Global Flow Cytometers Industry
11. Reportlinker Adds World Biometrics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/98rrmr/biometrics_for ... "Biometrics for Banking; Market & Technology Analysis, Adoption ... offering. The adoption for banking purposes ... the forecast is that by 2020 it will ... in delivering biometric systems to the banking industry. ...
(Date:7/8/2015)... 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... announced the launch of a study that aims ... Monitoring℠ (PCM) technology for predicting response to treatment ... combination of the novel immunotherapy agents Yervoy® (ipilumumab), ... inhibitor. The 50-patient study will be led by ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... attention. But a study led by McGill researcher Sarah Kimmins ... equally important role in the health of their offspring. It ... diets and of food insecurity. The research focused on ... range of green leafy vegetables, cereals, fruit and meats. It ...
... SAN FRANCISCO, Calif. , Dec. 10, 2013 ... today announced preliminary results of an ongoing multi-center ... (mAb), which the company is developing as a ... disease or who were unfit for chemotherapy have ...
... Whitesides, Ph.D., and David Edwards, Ph.D., have been named ... joining 141 other innovators elected this year. ... to academic inventors who have demonstrated a prolific spirit ... tangible impact on quality of life, economic development, and ...
Cached Biology News:You are what your father eats 2KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 2KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 3KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 4KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 5Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors 2Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors 3
(Date:7/29/2015)... DUBLIN , July 29, 2015 ... ) has announced the addition of the ... to their offering. The Global Biosimilars ... study of the rapidly growing biosimilars market. With ... industry striving to minimize costs, biosimilars are being ...
(Date:7/29/2015)... DIEGO , July 29, 2015  Pfenex Inc. ... 2015 financial results will be released on Thursday, August ... am Eastern Time, Pfenex management will host a conference ... business update.  A press release outlining the financial results ... the call. Please call 1-866-376-8058 (US) or ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris ... announced it has selected an optimized Erk inhibitor ... in the development of a new class of ... pathway represents a prime target for therapeutic intervention ... activities and survival benefits for B-Raf and Mek ...
(Date:7/29/2015)... Houston, TX (PRWEB) , ... July 29, 2015 , ... ... new levee system to protect the Orange County, Texas area from future ... the multi-firm design team in determining several potential levee alignment alternatives for providing protection, ...
Breaking Biology Technology:Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Preventing Storm Surge Flooding in Houston 2
... CITY, Calif., July 2 Pearl Therapeutics, Inc.,a ... announced that it has completed the closing of ... executed as an extension to,its first venture financing, ... round were Pearl,s existing investors Clarus Ventures, New ...
... July 2 Schering-Plough,Corporation (NYSE: SGP ... its,previously announced transaction with Virbac, S.A. to ... divestments were requested by the,European Commission as ... the,acquisition of Organon BioSciences N.V., In ...
... To effectively measure,customer satisfaction, follow-up CSR phone ... 5 among customer service and call center executives,in ... LLC,s GLOBAL,BENCHMARKING COUNCIL., However, only 35 percent ... the study,s health care segment not using follow-up ...
Cached Biology Technology:Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors 2Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction 2
... is designed for imaging of chemiluminescent, fluorescent ... offer direct control for users who wish ... hand , A range of high resolution, ... all fluorescent and chemiluminescent applications , ...
... SM22 alpha, also known as smooth muscle ... at high levels in various tissues such as ... with the regulatory protein, calponin. SM22 alpha expression ... smooth muscle in both vascular and visceral forms. ...
... system is designed for multiple user laboratories ... for TLC applications. The MultiDoc-It is available ... enclosure provides a darkroom environment and protects ... Use image capture and enhancement , ...
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Biology Products: